Pharma Giants Ink $300M Deal To End Glumetza Antitrust Suit
By Christopher Cole · September 9, 2021, 5:03 PM EDT
Direct buyers of Glumetza are floating a $300 million deal in California federal court with Bausch Health and several subsidiaries accused of plotting to stave off the blockbuster blood sugar drug's...
To view the full article, register now.